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ABstract  A mouse anterior pituitary tumor cell line (AtT-20) that secretes adrenocorticotropin 
and ~ endorphin  sorts the proteins it transports to the surface  into two exocytotic  pathways. 
AtT-20 cells  also synthesize a secretory granule-specific  sulfated  molecule  and  secrete  it on 
stimulation  (Moore, H.-P.,  B. Gumbiner, and  R. B.  Kelly,  1983, J. Cell Biol.,  97:810-817). We 
show here that this molecule is sensitive  to proteolysis and that the residual  sulfated  material 
co-migrates  with  a chondroitin  sulfate  standard  on  thin-layer  electrophoresis.  Furthermore, 
this  sulfated  molecule  is  completely  sensitive  to  chondroitinase  ABC  digestion.  Thus  the 
secretory granule-specific  sulfated  molecule  is a proteoglycan  with  chondroitin  sulfate  side 
chains.  We  examined  the  role of proteoglycans  in  the sorting and  secretion  of adrenocorti- 
cotropin in AtT-20 cells by severely decreasing the amount of this vesicle-specific  proteoglycan 
in two ways. First, a xyloside was used to inhibit proteoglycan  biosynthesis; second, a variant 
of the  AtT-20  cell  line  was  isolated  that  synthesized  little  of the  sulfated  proteoglycan.  In 
neither case was the sorting or secretion of adrenocorticotropin  detectably altered, suggesting 
that the proteoglycan is not required for these processes. 
Although it has been more than ten years since proteoglycans 
were first proposed to play a  role in packaging of secretory 
proteins into  secretory granules (1),  the  hypothesis has still 
only  indirect  support.  Sulfated  proteoglycans and  sulfated 
glycoproteins have been  found in  many secretory granules 
including  zymogen  granules  (2),  pituitary  granules  (3-5), 
chromaftin granules (6), and synaptic vesicles (7,  8). Proteo- 
glycans and sulfated glycoproteins appear to interact with the 
contents of secretory granules in several cell types. Sulfated 
glycosaminoglycan chains can cause aggregation of zymogen 
granule contents in vitro (9), mast cell granule contents stay 
aggregated after exocytosis (10),  and prolactin granule con- 
tents remain aggregated even after membrane removal (3, 4, 
11). Such interaction between proteoglycans and vesicle con- 
tents could permit them to carry secretory proteins from the 
Golgi complex to the  condensing  vacuoles, or to condense 
the contents of newly formed secretory organelles. 
The  role  of proteoglycans  in  sorting  and  packaging  of 
secretory proteins  into  secretory granules  can  be tested  by 
using a  secretory cell line, AtT-20, derived from a tumor of 
the mouse pituitary (12). In AtT-20 cells there are apparently 
two pathways of secretion  (13).  A  viral membrane protein 
encoded by an endogenous leukemia virus and the precursor 
of adrenocorticotropin  (ACTH)  ~ are  externalized  constitu- 
tively, that  is,  rapidly without  storage or regulation.  These 
cells  also  have  a  regulated  pathway  in  which  the  ACTH 
precursor, proopiomelanocortin (POMC), is processed to ma- 
ture  ACTH,  stored  in  secretory  granules,  and  specifically 
released in response to secretagogues. The sorting mechanism 
appears to be universal for peptide hormones since, when the 
proinsulin gene is expressed in  AtT-20 cells,  the proinsulin 
product is also stored and processed in a manner comparable 
to POMC (14).  The nature of the recognition signal on the 
prohormones responsible for sorting into the two pathways is 
unknown at present. It does not seem to involve asparagine- 
linked sugars (15). 
We have tried to assess the importance of proteoglycans in 
the regulated secretory pathway of AtT-20 cells. We find that 
a major sulfated component of secretory granules is a chon- 
i Abbreviations used in this paper:  ACTH, adrenocorticotropic hor- 
mone; POMC, proopiomelanocortin. 
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into the regulated pathway. To determine whether this pro- 
teoglycan might be involved in sorting or packaging of  ACTH, 
we isolated a variant that made greatly reduced levels of that 
proteoglycan  and  used  drugs  that  perturbed  proteoglycan 
biosynthesis. In neither case was the sorting, storage, or release 
of ACTH significantly affected. The data presented here sug- 
gest that sulfated glycosaminoglycan side chains are not re- 
quired for storage and release of ACTH. 
MATERIALS  AND  METHODS 
Materials:  [~sS]Methionine  and [35S]sulfate  were from Amersham Corp. 
(Arlington Heights, IL). 8-Br-cAMP, iodoacetamide, phenylmethylsulfonyl flu- 
oride, poly-o-lysine, 4-methyl umbelliferyI-B-D-xyloside,  chondroitinase  ABC, 
and Type VI bacterial protease (Pronase E) were from Sigma Chemical Co. (St. 
Louis, MO). Reagents for SDS polyacrylamide gels were obtained  from Bio- 
Rad Laboratories (Richmond, CA). En3Hance was from New England Nuclear 
(Boston, MA) and dialysis tubing was from Spectrum  Medical (Los Angeles, 
CA). 0.45-#m  pore membrane filters, type  HA,  were from Millipore Corp. 
(Bedford, MA) and thin-layer cellulose strips were from Gelman Sciences, Inc., 
(Ann Arbor, MI). Chondroitin  sulfate (4- and 6-sulfates) and heparan  sulfate 
were gifts from Dr. David Simpson (Laboratory of Biomedical and Environ- 
mental Sciences, University of California at Los Angeles). Antisera and other 
reagents for the ACTH radioimmunoassay and immunoprecipitation  have been 
described (16). 
Cell Culture and Metabolic  Labeling with [3S5]Methionine 
and [35515ulfate:  AtT-20/D-16V  cells were cultured  as described (16), 
except that cells were grown on poly-D-lysine-treated tissue culture dishes to 
minimize cell loss. [35S]Methionine pulse labeling was carded  out after a 20- 
min starvation  in mcthionine-free  medium.  Cells were labeled at 37"C with 
150  #Ci  [35Slmethionine/ml  for 20  min. Two consecutive  1-h chases were 
carded out in medium without serum. Secretion was stimulated by the addition 
of 5 mM  8-Br-cAMP to the chase  medium.  Media  and  cell extracts  were 
routinely treated with 0.3 mg/ml phenylmethylsulfonyl fluoride and iodoacet- 
amide. 135SlSulfate labeling was carried out in a similar fashion, except that the 
labeling period and amount of label varied with each experiment. Details are 
given in the figure legends. 4-Methyl umbelliferyI-B-D-xyloside  was used at 0.5- 
1.0 mM concentrations  to inhibit proteoglycan synthesis. Cells were pretreated 
at least 30 min before radiolabeling and throughout each experiment. 
SDS Gel Electrophoresis and Fluorography:  10-18%  exponen- 
tial gradient SDS polyacrylamide gels were performed according to the method 
of Laemmli (17). Gels were impregnated  with En3Hance, dried, and exposed 
to Kodak XAR5 film at -80°C. Fluorograms were scanned with an LKB soft 
laser scanning  densitomer  (LKB  Instruments,  Inc.,  Gaithersburg,  MD)  for 
quantitation. 
Gel Purification of Radiolabeled Material:  After electrophore- 
sis, SDS polyacrylamide gels were stained with Coomassie Brilliant Blue, and 
the molecular  weight standards  were used as markers to cut desired regions 
from the wet gel. Proteins were eluted exactly as described by Hager and Burgess 
(18). Acetone precipitates were dried and resuspended in the desired buffer. 
Enzymatic Digestions:  Proteolysis was carried out on gel purified, 
radiolabeled samples by incubation  with Pronase E at 3 mg/ml, 37*(7 for 18 h 
in 50 mM ethanolamine,  pH 7.2. 
Chondroitinase digestions were carried out on radiolabeled medium samples 
after dialysis and resuspension in 50 mM Tris, pH 7.5, 100 mM sodium acetate, 
and 0.2 mg/ml BSA. 0.05 U of  chondroitinase ABC was added and the reaction 
was incubated at 37°C for 1.25 h. 
Thin-layer  Electrophoresis:  Protease-digested  samples  in  0.2  M 
calcium  acetate  were spotted  onto mylar-supported  cellulose electrophoresis 
strips. Electrophoresis was carded out in 0.2 M calcium acetate at 5 mA for 
1.5  h.  Standard  glycosaminoglycans were  visualized by staining  with  0.1% 
Alcian  blue  8GN  (Matheson  Coleman  and  Bell Manufacturing  Chemists, 
Norwood. OH) in 10% acetic acid. 
Screening for Stimulated  Sulfate Release Variants of At  T-20 
Cells:  AtT-20  cells were plated at low density so that individual  colonies 
could be picked and cloned. After expanding the cloned cultures, 2-cm  2 wells 
were seeded and grown to confluence. The ceils were then starved and labeled 
with [35S]sulfate at 20-50  #Ci/well  for 3 h. After  l  h of chase, fresh medium 
was added to duplicate wells, with or without the addition of 8-Br-cAMP. After 
an additional  hour of chase this  medium was collected and  filtered onto a 
Millipore membrane filter. After extensive washing with 100 mM HEPES, pH 
7.4, and  100 mM potassium sulfate, the filter was dried and exposed to x-ray 
2224  T.E  JOURNAL  OF  CELL  BIOLOGY  .  VOLUME 99, 1984 
film. The intensity of spots  from stimulated and unstimulated samples were 
compared to identify clones that did not exhibit enhanced release  of sulfated 
material in the presence of the secretagogue  8-Br-cAMP. 
RESULTS 
AtT-20 Cells Synthesize,  Store,  and Secrete a 
Sulfated Proteoglycan 
It has been suggested that the secretory granules of AtT-20 
cells, like those of many exocrine and endocrine cells, contain 
a proteoglycan (16).  The suggestion came from the observa- 
tion  that  purified  secretory  granules  contained  a  sulfated 
macromolecule with a characteristic mobility on SDS PAGE 
very similar to that of the glycosaminoglycan oligosaccharides 
described  by  Hampson  and  Gallagher  (19).  Storage  of the 
sulfated material in the cell paralleled that of mature ACTH 
and it was coordinately secreted with  mature ACTH  when 
the cells were stimulated to secrete by the addition of 8-Br- 
cAMP to the medium. We have used enzymatic and physical 
methods to show that the sulfated  material has indeed  the 
properties of a proteoglycan. 
The unusual electrophoretic mobility of the granule-specific 
sulfated macromolecule is shown in Fig.  1. Cells were labeled 
with [35S]sulfate for 3.5  h and chased for 1.5 h. These condi- 
tions allow most of the sulfated material to be secreted from 
the  cell,  except  that  stored  in  secretory granules  (16).  The 
FIGURE  t  AtT-20 cells secrete a sulfated "staircase" upon stimula- 
tion with cAMP. Cells were labeled for 3.5 h with [3SS]sulfate at 250 
#Ci/m],  followed  by  a  1.5-h  chase.  Chase  medium  with  (+)  or 
without (-) 5 mM 8-Br-cAMP was collected from an equal number 
of cells after an additional 1.5 h chase and concentrated by trichlo- 
roacetic acid precipitation. Samples were run on a I 0-18% gradient 
SDS polyacrylamide gel. The fluorogram was exposed for 2 wk. sulfated material released  from the  cells in  the  next  1.5  h, 
either in the absence of stimulation or stimulating with 8-Br- 
cAMP,  was  collected,  concentrated  and  analyzed  by  SDS 
PAGE. It is clear that secretagogue stimulation enhances the 
release of sulfated material,  including bands in  an  unusual 
"staircase"  arrangement  with  Mr  in  the  range  of 25,000- 
35,000. 
To determine whether this "staircase" material contained 
protein, we eluted it from the gel and digested it extensively 
with protea~e. When protease-digested material was compared 
with  the  undigested  material  by  SDS  PAGE,  the  patterns 
shown in Fig.  2 were obtained. Exposure to protease did not 
destroy the sulfate-labeled material, but increased its electro- 
phoretic  mobility.  Note  that  the  characteristic  pattern  of 
bands  is  preserved  in  the  protease-digested  material.  This 
result shows that the characteristic set of sulfate-labeled bands 
contain a protein component and also that the heterogeneity 
is not due to the protein core. 
The banded structure disappears, however, after treatment 
with chondroitinase.  Sulfated material released into the me- 
dium  during  stimulation  with  8-Br-AMP was treated with 
chondroitinase  ABC  (or AC) and  analyzed by SDS  PAGE 
(Fig. 3 a). Whereas other sulfated components were unaffected 
by chondroitinase digestion, the characteristic staircase pat- 
tern  disappeared.  As further evidence that the  sulfate label 
was associated with glycosaminoglycans of the  chondroitin 
sulfate type, secreted material was treated with protease as in 
FIGURE 2  Pronase  diges- 
tion  of  the  sulfated  stair- 
case  increases  its  electro- 
phoretic mobility but does 
not  change  the  banded 
pattern. The sulfated stair- 
case from a  [35S]sulfate-la- 
beled medium sample was 
gel-purified  and  digested 
with  protease  (see  Mate- 
rials  and  Methods).  Both 
the digested (+) and undi- 
gested (-) samples were ly- 
ophilized, resuspended  in 
SDS sample buffer, and re- 
run side by side on a sec- 
ond  10-18%  SDS  polyac- 
rylamide  gel.  The  fluoro- 
gram was exposed for  ~1 
mo. (O) Denotes the begin- 
ning of the separating gel. 
FIGURE  3  The sulfated staircase  is a chondroitin sulfate proteogly- 
can.  (a) The sulfated staircase  is sensitive to chondroitinase ABC 
digestion. Cells labeled for 4.5  h  with  [3SS]sulfate at 400 ~.Ci/ml 
were stimulated with  8-Br-cAMP  for  1 h.  Medium was collected 
and one half of the sample was digested with chondroitinase ABC. 
Both samples were analyzed on the same 10-18% SDS polyacryl- 
amide gel. The fluorogram was exposed for 15 h.  (-) Without and 
(+)  with  chondroitinase ABC added. (b)  Pronase-treated staircase 
material co-migrates with chondroitin sulfate on thin-layer cellulose 
acetate electrophoresis. Gel-purified  [35S]sulfate-labeled  staircase 
material was prepared and pronase-digested as described  in  Ma- 
terials and  Methods.  The  pronase-treated (+)  and  -untreated  (-) 
samples as well as standard glycosaminoglycans were electropho- 
resed  on  the  same  thin-layer  cellulose  strip.  [3SS]sulfate-labeled 
material  was  detected  by  autoradiography. A  10-d  exposure  is 
presented.  Chs,  chondroitin  sulfate;  HS,  heparin sulfate; ori,  the 
origin of electrophoresis. 
Fig.  2,  and analyzed by thin-layer electrophoresis (Fig.  3 b). 
After protease digestion a  single spot was obtained that mi- 
grated close to a chondroitin sulfate standard. 
Thus, this sulfated macromolecule is sensitive to digestion 
with protease and chondroitinase, and the residue remaining 
after proteolysis has the same electrophoretic mobility as a 
chondroitin sulfate standard.  We conclude that the granule- 
specific sulfated staircase has the properties of a proteoglycan 
with chondroitin sulfate side chains. 
The Granule-specific Proteoglycan Has a High 
Molecular Weight Precursor 
If this  proteoglycan  is  involved  in  sorting  or  regulated 
secretion, it would be expected to partition into the regulated 
pathway at least as well as ACTH. Although we find little of 
the  characteristic  chondroitin  sulfate  proteoglycan released 
constitutively this is insufficient evidence to claim selective 
sorting. If  for example, the staircase form has a high molecular 
weight precursor, the apparent selectivity could result from a 
proteolytic activity that is restricted to the regulated route to 
the surface. This is not unreasonable since mature ACTH in 
secretory granules is generated from a large precursor, POMC, 
by a  series  of proteolytic events  that  are  restricted  to  the 
regulated pathway (13,  20).  We find from pulse-labeling ex- 
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weight  precursor.  (a)  The  25,000-35,000-mol-wt  vesicle-specific 
proteoglycan  is  not  present  in  a  pulse-labeled  cell  extract  and 
appears only after 1 h of chase. AtT-20 cells were pulse-labeled for 
15  min with  [35S]sulfate  at  1.35  mCi/ml. Cell  extracts were made 
from identical dishes of cells immediately (lane 1), after 1 h of chase 
(lane 2), or after 2 h of chase, either minus (lane 3) or plus (lane 4) 
8-Br-cAMP  stimulation. Cell extracts made by trichloroacetic acid 
precipitation of a postnuclear supernatant were analyzed on a 10- 
18% SDS polyacrylamide gel. The fluorogram was exposed for  13 
d. (b) Pronase digestion of the 95,000-mol-wt band present in pulse 
cell extracts generates a low molecular weight ladder indistinguish- 
able  from  that  produced  by  pronase  digestion  of  the  25,000- 
35,000-mol-wt  vesicle-specific  proteoglycan,  The  95,000-mol-wt 
region of a gel identical to that shown in lane 1 of a was eluted and 
digested with  pronase as described in Materials and Methods. (-) 
Undigested and (+) digested samples were rerun on the same 10- 
18% SDS polyacrylamide gel. Exposure was for 1 mo. 
periments that  the  proteoglycan in  secretory granules  may 
have a  large precursor.  When  cells  were pulse-labeled with 
[35S]sulfate for 15 min, none of the characteristic proteoglycan 
was observed in the cell extract (Fig. 4a, lane 1). Only after a 
l-hour  chase  period  did  the  staircase  material  appear.  To 
identify  the  region  of the  gel  that  might  contain  a  pulse- 
labeled precursor, we eluted bands of sulfated material from 
the gel and  subjected them to protease digestion as before. 
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Only material migrating with an Mr of 95,000 gave rise to the 
characteristic banded pattern (Fig. 4 b). This proteolytic prod- 
uct was indistinguishable from that generated by proteolysis 
of the isolated staircase material (compare with Fig. 2). If we 
assume  that  the  material  at  an  M~  of 95,000  is  indeed  a 
proteoglycan precursor, then some precursor is secreted con- 
stitutively  (Table  I).  The  final  "sorting  ratio"  is  however 
comparable to that found in similar experiments for ACTH 
and its precursor. The proteoglycan is sorted into  secretory 
vesicles at least as well as ACTH. 
Perturbation of Proteoglycan Biosynthesis by a 
Xyloside Inhibitor 
We have obtained further evidence that the sulfated mate- 
rial  is  a  proteoglycan and  that  it  is  selectively sorted  into 
secretory granules by using an inhibitor of proteoglycan bio- 
synthesis. The addition of glycosaminoglycans to the protein 
cores of some proteoglycans can be inhibited by xylose ana- 
logues,  since the first sugar added to the serine or threonine 
of the polypeptide backbone is a xylose (21, 22). AtT-20 cells 
were exposed to the xylose analogue 4-methyl umbelliferyl-~- 
D-xyloside (0.5  mM) for 30 min before labeling and through- 
out the experiment. After 3  h  of growth in  [35S]sulfate the 
cells were collected and the  sulfated material in  the extract 
was analyzed by SDS PAGE (Fig.  5). Under these conditions 
the proteoglycan is not detected by autoradiography.  How- 
ever,  the  characteristic  set  of bands again  appeared in  the 
presence  of the  xyloside  but  with  a  higher  electrophoretic 
mobility. The  number,  spacing,  and  mobility of the  bands 
were indistinguishable  from those  of the  sugar chains  that 
remained after protease treatment of the proteoglycan (com- 
pare Fig.  5 with Figs. 2 and 4b). These results are consistent 
with the mode of action of this class of inhibitors. They act 
as chain initiators for glycosaminoglycan biosynthesis and can 
effectively block  proteoglycan  glycosylation  by  competing 
with the protein core (23). 
It has been reported that  free glycosaminoglycan chains, 
induced  by treatment with a p-nitrophenyl-B-n-xyloside in- 
hibitor, may be directed into the secretory granules of mast 
cells (24).  If Golgi-synthesized glycosaminoglycans are selec- 
tively sorted into  secretory granules,  this would  imply that 
there is a  recognition system for glycosaminoglycan chains, 
unattached  to  protein.  To  test  if  free  glycosaminoglycan 
chains are sorted in our system, we pulse-labeled AtT-20 cells 
with [35S]sulfate for 15 min in the presence or absence of the 
proteoglycan synthesis inhibitor  4-methyl umbelliferyl-B-D- 
xyloside as described above. (This inhibitor may be preferable 
to  the  nitrophenyl  xyloside inhibitor since  the  nitrophenyl 
group could resemble the peptide core [24].) To estimate the 
amount of sulfated material released constitutively, first- and 
second-hour chase media were collected,  concentrated,  and 
analyzed by SDS PAGE.  We examined regulated release by 
having 8-Br-cAMP present during the second hour. The au- 
toradiograms were quantified by densitometry (Table I). Com- 
pared with proteoglycan sorting, only a minor fraction of the 
newly synthesized glycosaminoglycan chains entered the AtT- 
20 granules. The free glycosaminoglycan chains appear in the 
regulated pathway of secretion with an efficiency about 20- 
fold less than the vesicle-specific proteoglycan. This supports 
the claim that the proteoglycan is preferentially sorted into 
secretory granules  and  suggests  that  the  peptide  backbone 
may be involved. TABLE  I 
Sorting of the Vesicle-specific Proteoglycan  and the Free GIycosaminoglycan  Chain 
Without xyloside  With xyloside 
Homogenate  Medium 
Homog-  Me- 
Proteo-  Precur-  Proteo-  Precur-  enate  dium 
glycan  sor  glycan  sor  Total  GAG  GAG  Total 
0-1  h  72.1  1.8  ND  32.8  106.7  104  587  621 
1-2 h control  71.5  ND  ND  ND  71.5  69  83  152 
1-2 h stimulated  33.3  ND  51.1  ND  84.4  44  120  164 
Amount released (0-2 h) control (A)  ND  32.8  32.8  670  670 
increment released (1-2 h) on stimulation (B)  51.1  ND  51.1  37  37 
Sorting ratio (B/A)  1.6  0.06 
Following published procedures (16), ART-20  cells were pulse-labeled for 15 min with laSS]sulfate,  either in the presence  or the absence  of 4-methyl umbelliferyl- 
~-t)-xyloside, and then chased for  1 h. An aliquot  of cells was homogenized at the end of 1 h of chase and the sulfated proteins in the homogenate were 
analyzed by PAGE  (as in Fig. 4a). The amounts of the vesicle-specific proteoglycan or the free glycosaminoglycan  (GAG) chains in the presence of the xyloside 
inhibitor  were quantified  by densitometry of the autoradiographs. The sulfated proteins released by the cells into the medium during the same period were 
analyzed identically. Another two aliquots of cells were chased for a further  1-h period. The stimulated aliquot had 5 mM 8-Br-cAMP in the bathing medium; 
the control  had  none. At the  end  of the  labeling period  the  sulfated material released during  the  second hour  of chase, and that  remaining in the cell 
homogenates, were analyzed as before. To remain in the linear range of the photographic film, we exposed gels for different lengths of time and normalized 
them to a 2-d exposure. Recovery of the pulse-label was never <80%. ND, no detectable amount of the species in question. To measure  sorting it is necessary 
to look at the sum of precursor and mature forms. Since the half-time for constitutive release in these cells is ~40 rain (13, 16), the amount released in 2 h in 
the absence of stimulation is a reasonable measure of the amount leaving by the constitutive pathway. Stimulated release is the increment over the control 
ceils in the presence of 8-Br-cAMP. The ratio of stimulated release  to constitutive release, B/A, is a convenient measure  of sorting. 
FIGURE  5  The synthesis of the vesi- 
cle*specific proteoglycan is inhibited 
by  4-methyl  umbelliferyl-/3-D-xylo- 
side.  Cell  extracts  were  prepared 
after a  3-h  labeling with  [3SS]sulfate 
at 300/zCi/ml  by boiling cells in 2% 
SDS.  Only  a  low  molecular  weight 
ladder is detected in cells treated (+) 
with 4-methyl  umbellifery143-D-xylo- 
side for 30 min before and during the 
labeling  period  (compare  with  un- 
treated lane [-]). The fluorogram was 
exposed for 1 wk. 
A Variant AtT-20 Clone Lacks the Granule- 
specific Proteoglycan 
To establish the function of the granule-specific proteogly- 
can,  we  isolated  an  AtT-20  clone that  apparently lacks it. 
Clones  from  nonmutagenized  AtT-20  stocks  were  grown, 
labeled  with  [35S]sulfate,  and  screened  for  the  lack  of an 
enhanced release of [35S]sulfate when secretion was stimulated 
with 8-Br-cAMP. One clone discovered in this way, AtT--20/ 
CNB, did  not release the proteoglycan on stimulation (Fig. 
6). Cells of the CNB clone and AtT-20 cells were labeled for 
3.5 h with [35S]sulfate, chased for 1.5 h, and then exposed to 
8-Br-cAMP. While other sulfated proteins could be recognized 
in the medium upon stimulation, indicating that exocytosis 
was not blocked, the sulfated proteoglycan was absent (Fig. 6, 
lane 4). The lack of release cannot be explained by retention 
within the cell, since the proteoglycan is not observed even in 
extracts of the CNB clone (Fig. 6, lanes 7 and 8). This variant 
clone apparently can still make some sulfated secretory prod- 
ucts but not the granule-specific proteoglycan. 
Secretion of ACTH Is Not Affected by the 
Absence of the Vesicle-specific Proteoglycan 
Since we could lower the concentration of granule-specific 
proteoglycan in two ways, by using either the inhibitor of its 
biosynthesis or the variant clone AtT-20/CNB,  we asked if 
the proteoglycan was required for the storage and release of 
ACTH. Both wild-type and CNB cells were pretreated with 1 
mM xyloside inhibitor for 5 h before labeling and throughout 
the experiment. Inhibited and control cells were pulse-labeled 
for 20 rain with [35S]methionine  followed by a  1-h chase. As 
before, cells to be stimulated were exposed to 8-Br-cAMP for 
1 h  after the chase. To detect secreted hormone, we immu- 
noprecipitated  the  labeled  ACTH  from the  medium  using 
affinity-purified antibodies, analyzed it by SDS PAGE, and 
quantified  it  by  densitometry.  The  absence  of detectable 
amounts  of the  proteoglycan,  either  in  the  clone  CNB  or 
induced by the xyloside inhibitor, did not prevent or reduce 
the stimulated release of mature ACTH (Fig.  7 a). Since the 
amount of ACTH released did not decrease when the level of 
the proteoglycan was drastically reduced, it appears that sort- 
ing occurs normally even when the  proteoglycan is absent 
from the secretory granules. 
To confirm these  results by an independent  method, we 
analyzed secretion  of total  ACTH by using  a  radioimmu- 
noassay. Cells were treated with xyloside as described above 
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The  secretory granules  of AtT-20  cells,  like those  of other 
endocrine and exocrine cells, contain high concentrations of 
secretory products. There are an estimated 16,000  molecules 
of ACTH per secretory vesicle of 200  nm  diam  in  AtT-20 
cells (25).  A  molecular mechanism that  might simplify the 
sorting and packaging of ACTH would be a carrier molecule 
that  could  recognize and  bind  many hormone peptides  si- 
multaneously, and transport them out of the Golgi apparatus. 
Attractive candidates for such carrier proteins are the sulfated 
proteoglycans and  sulfated glycoproteins that  are  found  in 
many secretory granules.  We have identified and character- 
ized a  secretory granule-specific component in AtT-20 cells 
that  appears to  be  a  chondroitin  sulfate proteoglycan.  We 
have  tried  to  determine  the  role  of this  proteoglycan  by 
reducing  its  amount  in  AtT-20  cells  but  have  found  no 
detectable effect on sorting, storage, or secretion of ACTH. 
There are several explanations for this negative result. One 
is that only a  small amount of the  vesicle-specific staircase 
proteoglycan is required for sorting and packaging of ACTH. 
If  this is the case, the amount must be very small. In xyloside- 
treated cells we cannot detect the proteoglycan by autoradiog- 
raphy. In variant CNB,  it is detectable although at <5%  of 
the normal amount.  To reduce the  level further we treated 
the variant CNB with the xyloside inhibitor. Although a slight 
reduction  in the regulated secretion of ACTH was observed 
FIGURE  6  A  variant AtT-20 clone CNB  lacks the vesicle-specific 
proteoglycan. AtT-20 cells or variant CNB  cells were labeled with 
[3SS}sulfate at 250/~Ci]ml for 3 h and chased for 1 h in unlabeled 
medium. Material released into the medium in the next hour period, 
either with (lanes 2 and 4) or without (lanes  I  and 3) stimulation 
was analyzed by SDS PAGE. Cell extracts were prepared after the 
chases  by  boiling  cells  in  2%  SDS. Lanes  6  and  8  were  from 
stimulated cells,  and  lanes  5  and  7  from  unstimulated controls. 
Lanes 3, 4, 7, and 8 were from the variant CNB cell line; the others 
were from normal ART-20 cells. The bands visible in the CNB variant 
(Mr  16,000-18,000) are probably sulfated forms of the N-terminal 
peptides of  POMC,  peptides  known  to  have  asparagine-linked 
oligosaccharides. 
and media with and without cAMP from duplicate dishes of 
cells were assayed for ACTH. As can be seen in Fig.  7 b, the 
secretion of total ACTH was unaffected in variant CNB and 
in  cells treated with xyloside. Furthermore, when secretory 
granules  were  purified  from either  CNB  cells  or  xyloside- 
treated AtT-20 cells, they contained normal levels of ACTH 
by radioimmunoassay and were recovered at the same density 
(data not presented). Taken together these data strongly sug- 
gest that although the AtT-20 cells make a specific chondroitin 
sulfate proteoglycan and segregate it into secretory granules, 
it  is  not  required  for  sorting  or  release  of ACTH.  If,  as 
suggested earlier (25), the high density of the secretory vesicles 
is  due  to their ACTH content,  we have no  evidence for a 
reduction in storage. 
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FIGURE  7  The secretion of ACTH  is not altered by the absence of 
the granule-specific proteoglycan. (a)  Mature ACTH  detected by 
immunoprecipitation  is unaltered by xyloside treatment or in variant 
CNB.  Cells  treated  (+)  or  untreated  (-)  with  0.5  mM  4-methyl 
umbelliferyl-~-D-xyloside were pulse-labeled with [3SS]methionine 
and chased in unlabeled medium for 1 h; the culture medium was 
then collected in the absence (white bars) or presence (striped bars) 
of 8-BE-cAMP for 1 h. Labeled ACTH was immunoprecipitated  with 
affinity-purified anti-ACTH antibodies and analyzed by SDS PAGE. 
After fluorography, the film was analyzed by densitometric scanning 
and the amounts of mature ACTH (13,000= and 4,500-mol-wt forms) 
were determined by peak area integration. (b) Total ACTH detected 
by radioimmunoassay is not altered by xyloside or in variant CNB. 
A  radioimmunoassay was used  to determine the total ACTH  se- 
creted by ART-20 and CNB cells in the presence (+) or absence (-) 
of the proteoglycan synthesis  inhibitor 4-methyl umbelliteryl-~-D- 
xyloside, in  the  presence or absence of the  secretagogue,  8-13r- 
cAMP. The values presented are normalized to total cellular protein 
and represent the average of two to four experiments. (Fig. 7), this change was  not reproducible. Interpretation of 
the xyloside experiments is complicated by the ability of the 
xylosides to stimulate free glycosaminoglycan chain synthesis 
in AtT-20 cells (Table I). Thus, although free glycosamino- 
glycan chains are inefficiently  packaged into secretory  vesicles, 
the absolute amount of glycosaminoglycan chains present in 
granules is not altered by a very large amount owing to the 
stimulation  of glycosaminoglycan synthesis.  It  does  seem 
clear, however, from the  data  in  Table I  and Fig.  7,  that 
ACTH does not partition with the  free glycosaminoglycan 
chains. It is thus unlikely that ACTH associates with the sugar 
chains of the proteoglycan in either a sorting or condensing 
step. ACTH may partition with the protein core of the pro- 
teoglycan. However, there is currently no compelling reason 
to implicate this protein over any other intravesicular protein 
(16). Finally, it is possible that some other minor proteoglycan 
that we have not detected is responsible for the sorting and 
packaging of ACTH. Sulfated material is sometimes seen at 
the top of running gels (e.g., Fig.  1) with an electrophoretic 
mobility similar to that observed for proteoglycans (e.g., ref- 
erence 7). This material is apparently released constitutively, 
however, since its externalization is not dependent on 8-Br- 
cAMP  (Fig.  1).  A  proteoglycan that  is  not  sulfated  or  is 
insensitive to 4-methyl umbelliferyl-~-D-xyloside  could play a 
role in sorting. 
There is no evidence at present that posttranslational sul- 
fation of POMC is necessary for sorting. We have found that 
inhibition of  N-linked glycosylation  of  POMC by tunicamycin 
has no effect on sorting (reference 15 and A. Katzen and H.- 
P. Moore, unpublished observations). Although POMC and 
some of its products are sulfated in AtT-20 cells  as in the 
intermediate lobe of the rat pituitary (26), the sulfation is no 
longer detectable in cells grown in tunicamycin (H.-P. Moore, 
unpublished observations), presumably because the sulfation 
is occurring on N-linked oligosaccharides (27). Since sorting 
is not altered in the presence oftunicamycin, sulfation on N- 
linked sugars  of ACTH or other glycoproteins is apparently 
not required for ACTH sorting in AtT-20 cells. Indeed, several 
vesicle-specific  proteins  have  been  identified  that  are  not 
sulfated (16). 
Qualitatively similar results to those shown in Table I have 
been obtained using xyloside inhibitors to perturb proteogly- 
can biosynthesis in mast cells (24, 28). The material released 
into the medium without stimulation is relatively enriched in 
free  glycosaminoglycan  chains.  Some  glycosaminoglycan 
chains do arrive in the secretory vesicle and can be released 
from them by exocytosis. Quantitatively, however, a  much 
larger  fraction of the  free glycosaminoglycan chains  enter 
mast  cell  granules  than  enter  ACTH-containing granules. 
Several explanations for why free glycosaminoglycan chains 
might  be  directed to  secretory vesicles  in  mast  cells  have 
already been proposed (24). An additional possibility may be 
that constitutive secretion is a  minor route of secretion in 
mast  cells,  and  the  distribution  of free glycosaminoglycan 
chains perhaps reflects the relative internal volume of each 
pathway to the surface. 
The phenotype of the CNB variant is poorly understood at 
present. The rationale behind screening for secretory mutants 
was that whereas the constitutive pathway may be essential 
for cell growth, the regulated secretory pathway is not (13). 
Variants lacking that pathway might therefore be predicted to 
occur with high probability in a population of AtT-20 cells. 
In fact, in a screen of about 200 clones we found none that 
had lost the regulated secretory pathway for ACTH (H.-P. 
Moore, unpublished observations). In contrast, two variants 
that failed to secrete the sulfated material upon stimulation 
were found in a screen of only 15 clones. The expression of 
the vesicle-specific  sulfated proteoglycan thus appears to be 
an unstable characteristic of this cell line. The defect is prob- 
ably not  in  sulfation;  other secretory proteins are  sulfated 
normally (see Fig. 6). Morever, when CNB cells are treated 
with xyloside, they do have the ability to synthesize and sulfate 
a low molecular weight staircase that is indistinguishable from 
that made by AtT-20 cells, although less material is detected 
in CNB cells. Therefore, it is unlikely that reduction in 3'- 
phosphoadenosine-5'-phosphosulfate causes the variant phe- 
notype. It is also unlikely that the proteoglycan is turning over 
more slowly and  so  is  present in  normal amounts,  but  is 
undetectable by sulfate labeling.  The turnover time of this 
proteoglycan is regulated by its rate of secretion from the cell 
and there is no evidence that it is secreted more slowly in the 
CNB  variant.  An  intriguing parallel may be the  action of 
monensin  on  oligosaccharide synthesis.  At  low  monensin 
concentrations, sulfation of glycosaminoglycan chains stops 
but  sulfation  of N-linked  oligosaccharides continues  (29). 
Lacking an antibody to the proteoglycan, we are unable to 
distinguish  whether the polypeptide chain  is  absent in  the 
variant, or present but either not sulfated or not proteolytically 
processed correctly. 
If the  vesicle-specific  proteoglycans are  not  involved in 
transport or packaging of peptide hormones, an alternative 
function must be sought. The regulated pathway is clearly not 
the exclusive pathway of proteoglycan secretion since other 
cells that lack the pathway secrete proteoglycans. A possible 
role for granule-specific proteoglycans is based on the obser- 
vation that cholinergic synaptic vesicles contain an antigeni- 
cally unique proteoglycan-like material (7) that is also found 
extracellularly in the synaptic junctional region (30).  Since 
the  sites  of exocytotic transmitter  release  in  neurons  are 
confined to specialized domains of the plasma  membrane, 
extracellular matrix  components  externalized  via  synaptic 
vesicles could modify the extra-cellular matrix at the release 
sites. It is known that a unique region of extracellular matrix 
is associated with the exocytosis sites at neuromuscular junc- 
tions (31), where it plays a role in bringing the regenerating 
nerve terminal  in  register with  the  postsynaptic receptors. 
Perhaps  unique  proteoglycans in  the  secretory vesicles  of 
endocrine cells play a similar role in associating release sites 
with specialized extracellular domains. 
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